# Commission Regulation (EU) No 474/2014Show full title

Commission Regulation (EU) No 474/2014 of 8 May 2014 amending Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament            and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (‘REACH’) as regards 1,4-dichlorobenzene            (Text with EEA relevance)         

        - Previous
        - Next

U.K.

# Commission Regulation (EU) No 474/2014                     

# of 8 May 2014

# amending Annex XVII to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation,                        Authorisation and Restriction of Chemicals (‘REACH’) as regards 1,4-dichlorobenzene                     

# (Text with EEA relevance)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning                           the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency,                           amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as                           well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC(1), and in particular Article 68(1) thereof,                        

Whereas:

(1)A risk assessment on 1,4 dichlorobenzene (hereinafter ‘DCB’) was carried out by the French authorities in accordance with                              Council Regulation (EEC) No 793/93(2) on the evaluation and control of the risks of the existing substances appearing in the European Inventory of Existing Commercial                              Substances. The final report was published in 2004 on the European Chemicals Bureau website (EC, 2004)(3).

(2)In February 2008, the Commission communication(4) on the results of the risk evaluation and the risk reduction strategies for DCB was published in the *Official Journal of the European Union*. That communication recommended that, in order to limit the risk for consumers, marketing and use restrictions in Council                              Directive 76/769/EEC(5) should be considered for the use of DCB in air fresheners, moth repellents and toilet blocks. Restrictions on the use of                              DCB as a moth repellent, as recommended by that communication in 2008, are already covered by Commission Decision 2007/565/EC(6) (product type 19 — Repellents and attractants) and therefore restriction under Regulation (EC) No 1907/2006 is not necessary                              for that use.

(3)In November 2011, in accordance with Article 69(1) of that Regulation, the Commission requested the European Chemicals Agency                              (hereinafter ‘the Agency’) to prepare a restriction dossier for DCB conforming to the requirements of Annex XV to that Regulation                              (hereinafter ‘the Annex XV dossier’).

(4)In its request the Commission specifically asked the Agency to address the exposure of consumers at home and in public toilets,                              including the exposure of professionals attending or cleaning such toilets, taking into account the most recent and relevant                              information in scientific literature and the decline of the use of DCB in Europe. The report(7) commissioned by the Commission on the socioeconomic impacts of a restriction of DCB was also to be considered in this assessment.

(5)DCB is listed in part 3 of Annex VI to Regulation (EC) No 1272/2008 of the European Parliament and of the Council(8) as a carcinogen in hazard category 2, as well as for its eye irritation properties and its high toxicity to aquatic organisms,                              with long lasting effects. It is estimated that approximately 800 tonnes per year of DCB are used in the Union, for the manufacturing                              of air fresheners and toilet deodoriser products, of which 10 % is destined for domestic uses and the rest for professional                              uses (essentially as deodorisers in public toilets).

(6)On 19 April 2012, the Agency submitted to its Committee for Risk Assessment (hereinafter ‘RAC’) and to its Committee for Socio-Economic                              Analysis (hereinafter ‘SEAC’) the Annex XV dossier. In that dossier(9), it was demonstrated that the placing on the market and use of DCB-based air fresheners and toilet blocks should be restricted                              for both domestic and professional uses as risks associated with them are not adequately controlled and the benefits arising                              from the restriction outweigh the costs. The dossier further demonstrated that action on a Union-wide basis is necessary.

(7)On 8 March 2013, RAC adopted by consensus its opinion on the restriction proposed in the Annex XV dossier. According to the                              RAC opinion, the restriction is the most appropriate Union-wide measure to address the identified risks posed by DCB used                              as an air freshener or deodoriser in toilets, homes, offices or other indoor public areas, both in terms of effectiveness                              and practicability. However, RAC proposed to modify the restriction for enforceability reasons, specifying a concentration                              limit of 1 % by weight for DCB in such products, thereby avoiding products containing DCB as an impurity being unduly affected.                              That concentration corresponds to the limit value which triggers classification of a mixture as a category 2 carcinogen under                              Regulation (EC) No 1272/2008.

(8)As indicated in the background document to the RAC opinion, reliable analytical methods to determine contents of DCB are available                              on the Union market.

(9)In its assessment, RAC considered that carcinogenicity (mitogen, threshold carcinogen) is the end-point of greatest relevance                              to the human health. Based on data on inhalation exposure to DCB vapours, RAC proposed to reduce the identified risk to consumers                              when they use air fresheners and toilet deodorisers, containing DCB, continuously at home. That scenario was considered to                              represent reasonable worst-case conditions of exposure. In addition, the RAC opinion stated that exposure of professional                              toilet attendants and cleaners needs to be reduced as risk has been identified where toilets are poorly ventilated.

(10)In analysing the scope of the restriction RAC considered the exposure of consumers to air fresheners and toilet deodorisers                              in households and in public toilets as well as of professionals who work in public toilets, including toilet attendants and                              cleaners, but also other groups such as maintenance personnel. Consumers and professionals who visit and work in indoor areas                              (other than toilets) where air fresheners containing DCB are used were also considered. Other professional or industrial uses                              were not considered.

(11)On 5 June 2013, SEAC adopted by consensus its opinion on the restriction proposed in the Annex XV dossier. According to the                              SEAC opinion, the restriction, as modified by RAC and SEAC, is the most appropriate Union-wide measure to address the identified                              risks in terms of the proportionality of its socioeconomic benefits to its socioeconomic costs. Based on the RAC conclusion                              that exposures to DCB need to be reduced for domestic and professional users and some evidence that use of toilet blocks and                              air fresheners containing DCB will persist in the absence of any intervention, SEAC agreed that a restriction is an appropriate                              and an effective measure. Concerning proportionality of a restriction on domestic use, SEAC concluded that the measure is                              proportionate. Concerning the proportionality of a joint restriction on domestic and professional use, SEAC, taking account                              of the inferred health benefits and the scale of costs involved, concluded that the measure may not be considered to be disproportionate.

(12)The Forum for Exchange of Information on Enforcement was consulted during the restrictions process and their comments on the                              wording of the conditions of the restriction and on the transitional period were taken into consideration by RAC and SEAC.

(13)On 17 June 2013, the Agency submitted to the Commission the opinions of RAC and SEAC, based on which the Commission concludes                              that an unacceptable risk to human health arises from the placing on the market and use of DCB, as a substance or as a constituent                              of mixtures in a concentration equal to or greater than 1 % by weight, used as an air freshener or deodoriser in toilets,                              homes, offices or other indoor public areas. The Commission further considers that these risks need to be addressed on a Union-wide                              basis. The socioeconomic impacts of this restriction, including the availability of alternatives, have been taken into account.

(14)It is appropriate to provide for a period of 12 months after the entry into force of this Regulation within which stakeholders                              should take measures to comply with it, including for air fresheners and deodorisers that are already in the supply chain                              or in stock.

(15)Regulation (EC) No 1907/2006 should therefore be amended accordingly.

(16)The measures provided for in this Regulation are in accordance with the opinion of the Committee established under Article                              133 of Regulation (EC) No 1907/2006,

HAS ADOPTED THIS REGULATION:

# Article 1U.K.

Annex XVII to Regulation (EC) No 1907/2006 is amended in accordance with the Annex to this Regulation.

# Article 2U.K.

This Regulation shall enter into force on the twentieth day following that of its publication in the *Official Journal of the European Union*.                  

It shall apply from 1 June 2015.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 8 May 2014.

*For the Commission*                            

*The President*                            

José Manuel Barroso                            

## ANNEXU.K.

In Annex XVII to Regulation (EC) No 1907/2006, the following entry is added:

1

OJ L 396, 30.12.2006, p. 1.                           

2

Council Regulation (EEC) No 793/93 of 23 March 1993 on the evaluation and control of the risks of existing substances (OJ L 84, 5.4.1993, p. 1).                           

3

EU Risk Assessment Report on 1,4-dichlorobenzene. European Chemicals Bureau, Existing substances, Volume 48.

4

Commission communication on the results of the risk evaluation and the risk reduction strategies for the substances: Piperazine;                              Cyclohexane; Methylenediphenyl diisocyanate; But-2yne-1,4-diol; Methyloxirane; Aniline; 2-Ethylhexylacrylate; 1,4-Dichlorobenzene;                              3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone; Di-(2-ethylhexyl)phthalate; Phenol; 5-tert-butyl-2,4,6-trinitro-m-xylene                              (OJ C 34, 7.2.2008, p. 1).                           

5

Council Directive 76/769/EEC of 27 July 1976 on the approximation of the laws, regulations and administrative provisions of                              the Member States relating to restrictions on the marketing and use of certain dangerous substances and preparations (OJ L 262, 27.9.1976, p. 201).                           

6

Commission Decision 2007/565/EC of 14 August 2007 concerning the non-inclusion in Annex I, IA or IB to Directive 98/8/EC of                              the European Parliament and of the Council concerning the placing of biocidal products on the market of certain substances                              to be examined under the 10-year work programme referred to in Article 16(2) thereof (OJ L 216, 21.8.2007, p. 17).                           

7

RPA — Risk & Policy Analysts Limited (2010) Socio-Economic Evaluation arising from a Proposal for Risk Reduction Measures                              related to Restrictions on 1,4-Dichlorobenzene, Final Report — June 2010.                           

http://ec.europa.eu/enterprise/sectors/chemicals/documents/reach/studies/index_en.htm

8

Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling                              and packaging of substances and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and amending Regulation                              (EC) No 1907/2006 (OJ L 353, 31.12.2008, p. 1).                           

9

http://echa.europa.eu/documents/10162/3f467af2-66e0-468d-8366-f650f63e27d7